The Effect of Tire Design Parameters on the Force Transmissibility von Park, Woo Cheol, Lim, Hee Kyu, Jeong, Kyoung Moon, Kim, Tan Wan

Volltext

Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiven... von Tan, Aaron C., Lai, Gillianne G.Y., Tan, Gek San, Poon, Shou Yu, Doble, Brett, Lim, Tse Hui, Aung, Zaw Win, Takano, Angela, Tan, Wan Ling, Ang, Mei-Kim, Tan, Bien Soo, Devanand, Anantham, Too, Chow Wei, Gogna, Apoorva, Ong, Boon-Hean, Koh, Tina P.T., Kanesvaran, Ravindran, Ng, Quan Sing, Jain, Amit, Rajasekaran, Tanujaa, Lim, Alvin S.T., Lim, Wan Teck, Toh, Chee Keong, Tan, Eng-Huat, Lim, Tony Kiat Hon, Tan, Daniel S.W.

Volltext

Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma von Lim, Darren Wan-Teck, Kao, Hsiang-Fong, Suteja, Lisda, Li, Constance H., Quah, Hong Sheng, Tan, Daniel Shao-Weng, Tan, Sze-Huey, Tan, Eng-Huat, Tan, Wan-Ling, Lee, Justina Nadia, Wee, Felicia Yu-Ting, Jain, Amit, Goh, Boon-Cher, Chua, Melvin L. K., Liao, Bin-Chi, Ng, Quan Sing, Hong, Ruey-Long, Ang, Mei-Kim, Yeong, Joe Poh-Sheng, Iyer, N. Gopalakrishna

Volltext

Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer von Lai, Gillianne G Y, Lim, Tse Hui, Lim, John, Liew, Perry J R, Kwang, Xue Lin, Nahar, Rahul, Aung, Zaw Win, Takano, Angela, Lee, Yin Yeng, Lau, Dawn P X, Tan, Gek San, Tan, Sze Huey, Tan, Wan Ling, Ang, Mei-Kim, Toh, Chee Keong, Tan, Bien Soo, Devanand, Anantham, Too, Chow Wei, Gogna, Apoorva, Ong, Boon Hean, Koh, Tina P T, Kanesvaran, Ravindran, Ng, Quan Sing, Jain, Amit, Rajasekaran, Tanujaa, Yuan, Ju, Lim, Tony Kiat Hon, Lim, Alvin S T, Hillmer, Axel M, Lim, Wan Teck, Iyer, N Gopalakrishna, Tam, Wai Leong, Zhai, Weiwei, Tan, Eng-Huat, Tan, Daniel S W

Volltext

Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled tri... von Park, Keunchil, Prof, Tan, Eng-Huat, MD, O'Byrne, Ken, Prof, Zhang, Li, Prof, Boyer, Michael, Prof, Mok, Tony, Prof, Hirsh, Vera, Prof, Yang, James Chih-Hsin, Prof, Lee, Ki Hyeong, MD, Lu, Shun, Prof, Shi, Yuankai, MD, Kim, Sang-We, MD, Laskin, Janessa, MD, Kim, Dong-Wan, Prof, Arvis, Catherine Dubos, MD, Kölbeck, Karl, MD, Laurie, Scott A, MD, Tsai, Chun-Ming, Prof, Shahidi, Mehdi, MD, Kim, Miyoung, MD, Massey, Dan, PhD, Zazulina, Victoria, MD, Paz-Ares, Luis, MD

Volltext

Detection of circulating tumor DNA with ultradeep sequencing of plasma cell‐free DNA for monitoring minimal residual disease and early detection of recurrence in early‐stage lung c... von Tan, Aaron C., Lai, Gillianne G. Y., Saw, Stephanie P. L., Chua, Kevin L. M., Takano, Angela, Ong, Boon‐Hean, Koh, Tina P. T., Jain, Amit, Tan, Wan Ling, Ng, Quan Sing, Kanesvaran, Ravindran, Rajasekaran, Tanujaa, Kalashnikova, Ekaterina, Renner, Derrick, Sudhaman, Sumedha, Malhotra, Meenakshi, Sethi, Himanshu, Liu, Minetta C., Aleshin, Alexey, Lim, Wan‐Teck, Tan, Eng‐Huat, Skanderup, Anders J., Ang, Mei‐Kim, Tan, Daniel S. W.

Volltext

Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases von Tan, Wan-Ling, Ng, Quan Sing, Lim, Cindy, Tan, Eng Huat, Toh, Chee Keong, Ang, Mei-Kim, Kanesvaran, Ravindran, Jain, Amit, Tan, Daniel S W, Lim, Darren Wan-Teck

Volltext

Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study von Gainor, Justin F, Curigliano, Giuseppe, Kim, Dong-Wan, Lee, Dae Ho, Besse, Benjamin, Baik, Christina S, Doebele, Robert C, Cassier, Philippe A, Lopes, Gilberto, Tan, Daniel S W, Garralda, Elena, Paz-Ares, Luis G, Cho, Byoung Chul, Gadgeel, Shirish M, Thomas, Michael, Liu, Stephen V, Taylor, Matthew H, Mansfield, Aaron S, Zhu, Viola W, Clifford, Corinne, Zhang, Hui, Palmer, Michael, Green, Jennifer, Turner, Christopher D, Subbiah, Vivek

Volltext

Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and ne... von Iyer, N. Gopalakrishna, Tan, Daniel S.W., Tan, Veronique KM, Wang, Weining, Hwang, Jacqueline, Tan, Ngian‐Chye, Sivanandan, Ranjiv, Tan, Hiang‐Khoon, Lim, Wan Teck, Ang, Mei‐Kim, Wee, Joseph, Soo, Khee‐Chee, Tan, Eng Huat

Volltext

Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer von Shaw, Alice T, Kim, Dong-Wan, Mehra, Ranee, Tan, Daniel S.W, Felip, Enriqueta, Chow, Laura Q.M, Camidge, D. Ross, Vansteenkiste, Johan, Sharma, Sunil, De Pas, Tommaso, Riely, Gregory J, Solomon, Benjamin J, Wolf, Juergen, Thomas, Michael, Schuler, Martin, Liu, Geoffrey, Santoro, Armando, Lau, Yvonne Y, Goldwasser, Meredith, Boral, Anthony L, Engelman, Jeffrey A

Volltext

Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLC von Tan, Aaron C., Seet, Amanda O.L., Lai, Gillianne G.Y., Lim, Tse Hui, Lim, Alvin S.T., Tan, Gek San, Takano, Angela, Tai, David W.M., Tan, Tira J.Y., Lam, Justina Y.C., Ng, Matthew C.H., Tan, Wan Ling, Ang, Mei-Kim, Kanesvaran, Ravindran, Ng, Quan Sing, Jain, Amit, Rajasekaran, Tanujaa, Lim, Wan-Teck, Tan, Eng-Huat, Lim, Tony Kiat Hon, Tan, Daniel S.W.

Volltext

Concurrent Chemo-Radiation With or Without Induction Gemcitabine, Carboplatin, and Paclitaxel: A Randomized, Phase 2/3 Trial in Locally Advanced Nasopharyngeal Carcinoma von Tan, Terence, FRCR, Lim, Wan-Teck, MRCP, Fong, Kam-Weng, FRCR, Cheah, Shie-Lee, FRCR, Soong, Yoke-Lim, FRCR, Ang, Mei-Kim, MRCP, Ng, Quan-Sing, MRCP, Tan, Daniel, MRCP, Ong, Whee-Sze, MAppStats, Tan, Sze-Huey, MSc, Yip, Connie, FRCR, Quah, Daniel, FRCR, Soo, Khee-Chee, MD, Wee, Joseph, FRCR

Volltext

Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLC von Tan, Wan Ling, Chua, Kevin L.M., Lin, Chia-Chi, Lee, Victor H.F., Tho, Lye Mun, Chan, Anthony W., Ho, Gwo Fuang, Reungwetwattana, Thanyanan, Yang, James C., Kim, Dong-Wan, Soo, Ross A., Ahn, Yong Chan, Onishi, Hiroshi, Ahn, Myung-Ju, Mok, Tony S.K., Tan, Daniel S.W., Yang, Fan

Volltext

A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer von Ng, King Pan, Hillmer, Axel M, Chuah, Charles T H, Juan, Wen Chun, Ko, Tun Kiat, Teo, Audrey S M, Ariyaratne, Pramila N, Takahashi, Naoto, Sawada, Kenichi, Fei, Yao, Soh, Sheila, Lee, Wah Heng, Huang, John W J, Allen, John C, Woo, Xing Yi, Nagarajan, Niranjan, Kumar, Vikrant, Thalamuthu, Anbupalam, Poh, Wan Ting, Ang, Ai Leen, Mya, Hae Tha, How, Gee Fung, Yang, Li Yi, Koh, Liang Piu, Chowbay, Balram, Chang, Chia-Tien, Nadarajan, Veera S, Chng, Wee Joo, Than, Hein, Lim, Lay Cheng, Goh, Yeow Tee, Zhang, Shenli, Poh, Dianne, Tan, Patrick, Seet, Ju-Ee, Ang, Mei-Kim, Chau, Noan-Minh, Ng, Quan-Sing, Tan, Daniel S W, Soda, Manabu, Isobe, Kazutoshi, Nöthen, Markus M, Wong, Tien Y, Shahab, Atif, Ruan, Xiaoan, Cacheux-Rataboul, Valère, Sung, Wing-Kin, Tan, Eng Huat, Yatabe, Yasushi, Mano, Hiroyuki, Soo, Ross A, Chin, Tan Min, Lim, Wan-Teck, Ruan, Yijun, Ong, S Tiong

Volltext

Phase II study of nimotuzumab (TheraCim‐hR3) concurrent with cisplatin/radiotherapy in patients with locally advanced head and neck squamous cell carcinoma von Ang, Mei‐Kim, Montoya, Jose Enrique, Tharavichitkul, Ekkasit, Lim, Cindy, Tan, Terence, Wang, Lan Ying, Wee, Joseph, Soong, Yoke‐Lim, Fong, Kam‐Weng, Ng, Quan Sing, Tan, Daniel Shao‐Weng, Toh, Chee‐Keong, Tan, Eng‐Huat, Lim, Wan‐Teck

Volltext

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer von Solomon, Benjamin J, Mok, Tony, Kim, Dong-Wan, Wu, Yi-Long, Nakagawa, Kazuhiko, Mekhail, Tarek, Felip, Enriqueta, Cappuzzo, Federico, Paolini, Jolanda, Usari, Tiziana, Iyer, Shrividya, Reisman, Arlene, Wilner, Keith D, Tursi, Jennifer, Blackhall, Fiona

Volltext

Activity and safety of ceritinib in patients with ALK -rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial von Kim, Dong-Wan, MD, Mehra, Ranee, MD, Tan, Daniel S W, MD, Felip, Enriqueta, MD, Chow, Laura Q M, MD, Camidge, D Ross, Prof, Vansteenkiste, Johan, Prof, Sharma, Sunil, Prof, De Pas, Tommaso, MD, Riely, Gregory J, MD, Solomon, Benjamin J, MBBS, Wolf, Jürgen, Prof, Thomas, Michael, Prof, Schuler, Martin, Prof, Liu, Geoffrey, MD, Santoro, Armando, Prof, Sutradhar, Santosh, PhD, Li, Siyu, PhD, Szczudlo, Tomasz, MD, Yovine, Alejandro, MD, Shaw, Alice T, Dr

Volltext

PD-L1 score as a prognostic biomarker in asian early-stage epidermal growth factor receptor-mutated lung cancer von Saw, Stephanie P.L., Ng, Win Pin, Zhou, Siqin, Lai, Gillianne G.Y., Tan, Aaron C., Ang, Mei-Kim, Lim, Wan-Teck, Kanesvaran, Ravindran, Ng, Quan Sing, Jain, Amit, Tan, Wan Ling, Rajasekaran, Tanujaa, Chan, Johan W.K., Teh, Yi Lin, Pang, Mengyuan, Yeo, Jia-Chi, Takano, Angela, Ong, Boon-Hean, Tan, Eng-Huat, Tan, Sze Huey, Skanderup, Anders J., Tan, Daniel S.W.

Volltext

Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma von Tan, Daniel S W, Chong, Fui Teen, Leong, Hui Sun, Toh, Shen Yon, Lau, Dawn P, Kwang, Xue Lin, Zhang, Xiaoqian, Sundaram, Gopinath M, Tan, Gek San, Chang, Mei Mei, Chua, Boon Tin, Lim, Wan Teck, Tan, Eng Huat, Ang, Mei Kim, Lim, Tony K H, Sampath, Prabha, Chowbay, Balram, Skanderup, Anders J, DasGupta, Ramanuj, Iyer, N Gopalakrishna

Volltext

EGFR Mutation Subtypes Influence Survival Outcomes following First-Line Gefitinib Therapy in Advanced Asian NSCLC Patients von Sutiman, Natalia, Tan, Shao Weng, Tan, Eng Huat, Lim, Wan Teck, Kanesvaran, Ravindran, Ng, Quan Sing, Jain, Amit, Ang, Mei Kim, Tan, Wan Ling, Toh, Chee Keong, Chowbay, Balram

Volltext